Position in NBIX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,475,224
-$265,171 QoQ
Shares Held
11,198
-8.7% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026HighTower Advisors, LLC holds $76,791,783 across 32 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
419,904 | $49,636,851 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
224,067 | $6,748,898 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
4,894 | $2,902,044 | |
| 4 | HLN |
Haleon plc
|
192,177 | $1,923,691 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
103,082 | $1,909,078 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
This page
|
11,198 | $1,475,224 | |
| 7 | VTRS |
Viatris Inc
|
108,052 | $1,459,782 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
93,386 | $1,160,787 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,475,224 | 11,198 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,740,395 | 12,271 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,326,450 | 9,449 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,214,542 | 9,663 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,071,050 | 9,684 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,446,900 | 10,600 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,104,614 | 9,587 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,043,643 | 29,372 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,198,168 | 15,938 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $2,026,732 | 15,382 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $813,712 | 7,233 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $623,134 | 6,608 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $800,144 | 7,905 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $989,679 | 8,286 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $609,220 | 5,736 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $564,701 | 5,793 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $538,593 | 5,745 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $328,926 | 3,862 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $575,843 | 6,004 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,148,107 | 32,348 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $577,859 | 5,942 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $548,070 | 5,718 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $786,877 | 8,183 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $555,344 | 4,552 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $405,313 | 4,683 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||